As a lender of last resort Oaktree are no angels but the difference of say Bluesky and MSB is we are not in a position as of 10 am where the shorters control the narrative MSB can now concentrate on the FDA application process without the added presure of a cratering shareprice and a capital raise just when they are trying to negotiate financial agreements with partners who would have used the pressue of the market to screw MSB
A completely new negotiating landscape has opened up to MSB now this has relieved the pressure
If the FDA does not approve that when it will get sticky with Oaktree but lets cross that bridge first before we throw the baby out with the bathwater
This has enabled MSB to get to the next stage …can’t say how big this is
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility, page-39
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |